MHRA approval Mesalazine is a significant milestone for Bliss GVS in pharma.
Korean gastritis treatment: Proven once-daily option approved
Korean gastritis treatment has received approval for a proven once-daily solution, offering patients a new hope for managing their condition.
Sun Pharma ILUMYA Approval: A Proven Treatment for Arthritis
Sun Pharma ILUMYA approval marks a significant advancement in psoriatic arthritis treatment options.
Psilocybin pill for depression: Proven treatment option
Psilocybin pill for depression shows promise as a proven treatment option for those struggling with mental health issues.
Tavneos Approval Japan: The Worst Data Doubts Revealed
Tavneos approval Japan is under scrutiny due to data doubts. Find out what this means for patients and the pharmaceutical industry.
Anti-Cancer Drugs Price Control: India’s Smart Move to Save Lives
Anti-cancer drugs price control is a smart move by India to improve healthcare access.
Egyptian medicine prices: Worst rise expected in January 2027
Egyptian medicine prices may rise significantly in January 2027, impacting affordability and access for many citizens.
Medicine Price Transparency: The Right Path to Honest Costs
Medicine price transparency is crucial for consumers seeking fair healthcare costs.
Pan-RAS Inhibitor Approval: A Proven Breakthrough for Cancer
Pan-RAS inhibitor approval marks a significant milestone in cancer treatment.
Eli Lilly pharmaceutical plant: Is it the best investment?
Eli Lilly pharmaceutical plant is set to bring $3 billion investment to Katwijk, boosting the local economy and job market.